Value Chain & Products
Chemical Management System
We evaluate all substances placed on the market (> 1 metric ton p.a.). Particularly dangerous substances are included from lower amounts. That allows a soundly based assessment of the risks.
Where necessary, restrictions are placed on certain usage patterns or, in extreme cases, a complete ban is issued on use in certain products.
Evonik evaluates its substances using its own chemicals management system (CMS). This system supports us in the global evaluation of our substances. The content of the CMS has been harmonized with the requirements of ICCA and the REACH requirements. All substances that were added to our portfolio through acquisitions between 2017 and 2020 have already been included in the CMS and evaluated. We want to include and evaluate substances added through acquisitions between 2021 and 2023 by the end of 2026.
Chemicals Management SystemPLUS
As an extension of the CMS, our Chemicals Management SystemPLUS is used for products containing more than 0.1 percent substances of very high concern. Our aim is to reduce or replace these wherever possible. The precondition for this is a detailed analysis so that we can derive suitable action to bring about a further reduction in the possible negative effects on people and the environment. All products that were added to our portfolio through acquisitions between 2017 and 2020 have already been included in CMSPLUS and evaluated. We want to include and evaluate products added through acquisitions between 2021 and 2023 by the end of 2026.
Targets for 2024 and beyond
- Add substances/products that were added to our portfolio through acquisitions between 2021 and 2023 to CMS/CMSPLUS and process them by the end of 2026.